Taytulla is an oral hormonal contraceptive, containing ethinyl estradiol and norethisterone. The drug is used to prevent pregnancy.
Taytulla has the following indications for use:
- hormonal contraception due to inhibition of the ovulation cycle of the egg;
- regulation of your menstrual cycle;
- functional delays of menstruation;
- uterine bleeding in case of failure of menstruation;
- infertility (in complex treatment);
- underdevelopment of the uterus (hypoplasia);
- painful and prolonged menstruation;
- treatment of some gynecological diseases during menopause (only as prescribed by a doctor).
Two hormones, ethinyl estradiol and norethisterone, inhibit the function of the pituitary gland, which is responsible for the reproductive capacity of the female ovaries. In the pituitary gland, the endocrine gland cyclically removes a hormone that stimulates the maturation of the mature egg. When taking the drug, the hormone is not released, the egg does not mature.
Each pack of Taytulla contains 28 pills: 24 active pills and 4 inert pills (reminders),
The drug is available in a convenient blister strip packaging, with the days of the week for ease of use.
Take the first tablet is administered on the first day of menstruation. Take 1 tablet per day, preferably at the same time, with water, for 28 days in a row, without breaks. During the period of taking reminder pills, menstruation occurs. Regardless of whether menstruation occurs or not, start a new pack of the contraceptive without intervals.
The effect of the drug is achieved only with systematic use.
In preclinical studies, no serious adverse effects were observed as a result of an overdose.
Symptoms that may occur with an overdose of ethinyl estradiol and norethisterone include nausea, vomiting, spotting, vaginal bleeding.
In case of overdose, consult a doctor.
Like all hormones, Taytulla pills have a number of adverse reactions to the woman’s body. These include dizziness, indigestion, dark-bloody bleeding between menstruation, weight gain, swelling and hardening of the mammary glands, high blood pressure, vomiting, head migraines, candidiasis, chlamydia.
In some cases, the medication may change blood parameters, which can give a deceptive picture before starting a serious illness.
The use of Taytulla for birth control is contraindicated in some cases:
- malignant tumors and neoplasms of the mammary glands or the reproductive organs of the pelvis;
- lactose intolerance (the formulation contains lactose monohydrate);
- the period of treatment of gynecological diseases with other hormonal drugs;
- diabetes mellitus of the first and second type;
- chronic diseases of the liver, ducts of the gallbladder, urinary organs (kidneys, bladder);
- hormonal or functional metabolic disorders;
- transferred thromboembolism, the risk of new blood clots, impaired blood clotting;
- cardiovascular diseases, heart attacks, strokes, blood pressure surges;
- persons abusing smoking and alcohol;
- obesity of the second and third degree;
- vaginal bleeding associated with inflammatory processes of the epithelium of the vaginal walls;
- sickle cell anemia;
- at the first sign of pregnancy;
- breastfeeding period;
- yellowness due to increased bilirubin in the blood.
It is necessary to bear in mind that some medications can interact with hormonal contraceptives. Before using any medications, you need to inform your doctor about it.
Taytulla is contraindicated for a joint use with the following medications:
- drugs for the treatment of epilepsy (carbamazepine, topiramate, pyrimidone, barbiturates);
- antibiotics (ciprofloxacin, tetracycline, ofloxacin, ampicillin);
- drugs for the treatment of tuberculosis (rifampicin, rifabutin, sodium para-aminosalicylate).
Particular attention should be paid to insulin-dependent people, as ethinyl estradiol and norethisterone reduces the effect of insulin in the blood and may worsen the course of diabetes.
Taytulla is contraindicated in pregnancy. If pregnancy is detected while taking birth control pills, they should be immediately canceled.
Oral contraceptives can reduce the amount of breast milk and alter its composition, so their use is not recommended until breastfeeding is stopped. A small amount of sex hormones and/or their metabolites can penetrate into breast milk and affect the body of the newborn.
If you missed 1 active tablet:
- Take the tablet as soon as you remember. Take the next tablet at your usual time, even this means you have to take 2 tablets per day;
- You do not need to use an additional method of contraception if you have sexual intercourse.
If you missed 2 active tablets in a row in Week 1 or Week 2:
- Take 2 tablets on the day you remember and 2 tablets the next day;
- Then return to your usual schedule of taking 1 tablet per day until the pack is empty;
- You must use an additional method of contraception (condoms, spermicides) during the first 7 days after you missed the tablets.
If you missed 2 active tablets in a row in Week 3 or Week 4, OR if you missed 3 or more active pills in a row at any time:
Day 1 Starter
- Discard the rest of the tablets and start a new pack that same day.
- Continue taking 1 pill per day until Sunday. On Sunday, discard the rest of the tablets and start a new pack that same day.
In any case, an additional method of contraception (condoms, spermicides) during the first 7 days after you missed the tablets. You may not have a scheduled menstruation this month. If you miss 2 menstruations in a row, consult your doctor because you might be pregnant.
If you missed any of the 4 inert pills in Week 4:
- Discard the missed tablets;
- Continue taking 1 tablet per until you finish the pack;
- You do not need to use an additional method of contraception;
Start a new pack as soon as you finish the current one.
If you are not sure of what to do after missing tablets of Taytulla, you should consult your doctor. Use an additional method of contraception (condoms, spermicides) anytime you have sexual activity and continue taking 1 tablet per day until you consult your doctor.
Women who have entered the period of early menopause and who do not plan future pregnancies are recommended to use Taytulla with caution.
The risk of cardiovascular complications increases with smoking (especially after 35 years of age).
Before starting hormonal contraception, as well as every 6 months, you need to consult a gynecologist.
The risk of thrombosis increases with high blood pressure.
The drug must be immediately stopped if the following symptoms appear: early signs of phlebitis (inflammation of the vein wall), thrombosis (vascular occlusion with a blood clot), embolism (vascular impairment) – bloating of the veins, unusual leg pain, chest pain during breathing or coughing a feeling of tightness in the chest; first-time migraine-like headaches, sudden impairment of hearing and vision, movement disorders.
The drug must be discontinued 6 weeks before the planned surgery.
The drug is canceled with hepatitis, jaundice, itching, cholestasis (stagnation of bile in the bile ducts), increased epilepsy attacks, diseases associated with impaired metabolism of porphyrins/pigments).
Taking COCs on the background of antidiabetic therapy may change glucose tolerance (glucose tolerance).
Vomiting or diarrhea can lead to the removal of the active substances of Taytulla from the body, therefore, in cases where these symptoms persist within 1 day, you should take an additional pill. If these symptoms persist longer, you should temporarily use other methods of contraception.